| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Sep―14 |
Retracted: Severity Assessment of COVID-19 Using a CT-Based Radiomics Model |
Stem Cells International |
| 2 |
[GO] |
2023―Aug―18 |
Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review |
Po-Ren Hsueh, Sung-Jung Ho, Po-Chuen Hsieh, I-Min Liu, Shio-Shin Jean, Philippe Bourin |
| 3 |
[GO] |
2021―Sep―27 |
Severity Assessment of COVID-19 Using a CT-Based Radiomics Model |
Zhigao Xu, Lili Zhao, Guoqiang Yang, Ying Ren, Jinlong Wu, Yuwei Xia, et al. (+9) Xuhong Yang, Milan Cao, Guojiang Zhang, Taisong Peng, Jiafeng Zhao, Hui Yang, Jinfeng Hu, Jiangfeng Du, Juan Wang |
| 4 |
[GO] |
2021―Jun―08 |
Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update |
Lu Sang, Xiaoqin Guo, Jie Shi, Shike Hou, Haojun Fan, Qi Lv, Christian Morsczeck |
| 5 |
[GO] |
2021―May―07 |
Mesenchymal Stem Cells and COVID-19: Cure, Prevention, and Vaccination |
Mehrdad Afarid, Fatemeh Sanie-Jahromi, Marta Baiocchi |
| 6 |
[GO] |
2020―Dec―22 |
Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2 |
Karen J. Juárez-Navarro, Eduardo Padilla-Camberos, Néstor Fabián Díaz, Ariel Miranda-Altamirano, N. Emmanuel Díaz-Martínez, Andrea Ballini |
| 7 |
[GO] |
2020―Sep―24 |
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients |
Faisal A. Alzahrani, Islam M. Saadeldin, Abrar Ahmad, Dipak Kumar, Esam I. Azhar, Arif Jamal Siddiqui, et al. (+4) Bassem Kurdi, Abdulrahim Sajini, Abdulmajeed F. Alrefaei, Sadaf Jahan |
|
